Cantor Fitzgerald’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Cantor Fitzgerald’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250,000	Closed	-$14K	–	622
2023 Q3	$14K	Hold	250,000	–	–	﹤0.01%	503
2023 Q2	$36.9K	Hold	250,000	–	–	﹤0.01%	504
2023 Q1	$23.8K	Hold	250,000	–	–	﹤0.01%	603
2022 Q4	$25K	Hold	250,000	–	–	﹤0.01%	637
2022 Q3	$20K	Hold	250,000	–	–	﹤0.01%	687
2022 Q2	$35K	Hold	250,000	–	–	﹤0.01%	727
2022 Q1	$58K	Buy	+250,000	New	+$64.9K	﹤0.01%	326

Cantor Fitzgerald's BIOSW Position: Q4 2023 in Review

Cantor Fitzgerald sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 250,000 shares — an estimated $14K sold.

Cantor Fitzgerald first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $58K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Cantor Fitzgerald reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Cantor Fitzgerald sold 250,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $14K.
Cantor Fitzgerald first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Cantor Fitzgerald's BioPlus Acquisition Corp. Warrants position peaked at $58K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.